6-MAPDB

6-MAPDB (1-(2,3-dihydrobenzofuran-6-yl)-N-methylpropan-2-amine) is a chemical compound which might be an entactogenic drug. It is structurally related to drugs like 6-APDB and 6-MAPB, which have similar effects to MDMA and have been used as recreational drugs. 6-MAPDB has never been studied to determine its pharmacological activity, though it is the N-methyl derivative of 6-APDB which is known to be a selective serotonin releaser.^[1]

6-MAPDB

Legal status
Legal status	CA: Schedule I DE: NpSG (Industrial and scientific use only) UK: Class B
Identifiers
IUPAC name 1-(2,3-dihydro-1-benzofuran-6-yl)-N-methylpropan-2-amine
CAS Number	1354631-81-4
PubChem CID	112500534
ChemSpider	32078889
UNII	1C25E596YG
CompTox Dashboard (EPA)	DTXSID301045393
Chemical and physical data
Formula	C12H17NO
Molar mass	191.274 g·mol−1
3D model (JSmol)	Interactive image
SMILES CC(CC1=CC2=C(CCO2)C=C1)NC
InChI InChI=1S/C12H17NO/c1-9(13-2)7-10-3-4-11-5-6-14-12(11)8-10/h3-4,8-9,13H,5-7H2,1-2H3 Key:ZKMVEORLSJXOBD-UHFFFAOYSA-N

Legality

6-MAPDB was banned in the UK in June 2013 as a temporary class drug along with 9 other related compounds, despite having never been sold as a street drug itself. This was due to concerns that it would have similar effects to drugs such as 6-APB that had been widely sold already, and 6-MAPDB might therefore be likely to become used recreationally also, if it were not banned preemptively.^[2]

See also

• 5-MAPDB
• 5-MAPDI
• IBF5MAP